Literature DB >> 2401731

Virus infections in bone marrow transplant recipients: a three year prospective study.

C E Taylor1, L Sviland, A D Pearson, M Dobb, M M Reid, J Kernahan, A W Craft, P J Hamilton, S Proctor.   

Abstract

Over three years 81 consecutive bone marrow transplant recipients (32 allogeneic and 49 autologous) who received prophylaxis with acyclovir, were studied for symptomatic virus infection. Thirty nine infections were documented in a total of 28 patients. Thirty two infections were mild, five were moderately severe, and two were severe. Cytomegalovirus infection occurred in only six allogeneic recipients. Herpes simplex virus and varicella zoster virus infections occurred infrequently. Seven patients who were considered at the time of death to have died due to an infectious cause were studied virologically at necropsy. In only one patient was a virus infection thought to have been the cause of death. Prophylaxis with acyclovir may have influenced the rate and clinical prominence of herpes virus infections. In this study viruses were considered to have had a relatively minor role in causing morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2401731      PMCID: PMC502642          DOI: 10.1136/jcp.43.8.633

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.

Authors:  J D Meyers; E C Reed; D H Shepp; M Thornquist; P S Dandliker; C A Vicary; N Flournoy; L E Kirk; J H Kersey; E D Thomas
Journal:  N Engl J Med       Date:  1988-01-14       Impact factor: 91.245

2.  Incidence and prognosis of cytomegalovirus infections following allogenic bone marrow transplantation.

Authors:  D Guyotat; R Gibert; J Chomel; E Archimbaud; S Bossard; J Maupas; D Fiere; M Aymard
Journal:  J Med Virol       Date:  1987-12       Impact factor: 2.327

3.  A comparative study of methods for the diagnosis of respiratory virus infections in childhood.

Authors:  P M Sturdy; J McQuillin; P S Gardner
Journal:  J Hyg (Lond)       Date:  1969-12

Review 4.  Allogenic bone marrow transplantation: current status and future directions.

Authors:  R J O'Reilly
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

5.  Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party.

Authors:  A Bacigalupo; J Hows; E Gluckman; C Nissen; J Marsh; M T Van Lint; M Congiu; M M De Planque; P Ernst; S McCann
Journal:  Br J Haematol       Date:  1988-10       Impact factor: 6.998

6.  A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.

Authors:  H H Balfour; B A Chace; J T Stapleton; R L Simmons; D S Fryd
Journal:  N Engl J Med       Date:  1989-05-25       Impact factor: 91.245

7.  Infection with herpes simplex virus and cell-mediated immunity after marrow transplant.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1980-09       Impact factor: 5.226

8.  Varicella-zoster virus infection after marrow transplantation for aplastic anemia or leukemia.

Authors:  K Atkinson; J D Meyers; R Storb; R L Prentice; E D Thomas
Journal:  Transplantation       Date:  1980       Impact factor: 4.939

9.  Problems of infection after bone marrow transplantation.

Authors:  J G Watson
Journal:  J Clin Pathol       Date:  1983-06       Impact factor: 3.411

10.  Acyclovir prophylaxis of herpes-simplex-virus infections.

Authors:  R Saral; W H Burns; O L Laskin; G W Santos; P S Lietman
Journal:  N Engl J Med       Date:  1981-07-09       Impact factor: 91.245

View more
  5 in total

Review 1.  Prevention of viral infections after bone marrow transplantation.

Authors:  U Schuler; G Ehninger
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

2.  Viral findings during febrile episodes after cytotoxic chemotherapy in patients with hematological malignancies.

Authors:  E M Rintala; J Nikoskelainen; T Ziegler; R Jussila
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

3.  Management of herpes simplex virus type 1 pneumonia following liver transplantation.

Authors:  P Liebau; E Kuse; M Winkler; H J Schlitt; K Oldhafer; W Verhagen; J Flik; R Pichlmayr
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

4.  Visceral varicella zoster after bone marrow transplantation: an obscure cause of an "acute abdomen".

Authors:  Colm J O'Loughlin; Umaprasanna S Karnam; Jamie S Barkin
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.487

Review 5.  Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.

Authors:  R Snoeck; G Andrei; E De Clercq
Journal:  Drugs       Date:  1999-02       Impact factor: 11.431

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.